News | April 03, 2009

ICDs in Certain Heart Attack Patients Reduce Risk of Sudden Cardiac Death

April 3, 2009 - Results from the Medtronic-supported IRIS (Immediate Risk Stratification Improves Survival) clinical trial assessing the use of implantable cardiac devices (ICDs) in certain heart attack patients show a reduction in sudden cardiac death.
Study results, presented this week at ACC, showed that sudden cardiac death in a specific subset of immediate post-MI (myocardial infarction) patients was statistically significantly reduced with ICD therapy. However, in this narrowly defined patient population, ICDs did not reduce mortality from all causes, as all causes are not treatable by ICDs.
The IRIS trial sought to determine if survival amongst a subset of post-MI patients who were at high risk for sudden cardiac death could be improved by ICD therapy received in the first 31 days after a heart attack.
The patients selected for the trial were in the immediate post-MI stage (days five - 30), and based on selective criteria, represent less than five percent of those who have suffered a heart attack. The trial involved 902 patients at 92 centers in seven countries in Europe.
The IRIS results do not conflict with previous data that informed current evidence-based treatment guidelines which showed that use of ICDs in a more broadly defined range of post-MI patients (those who received ICD therapy at least 40 days after experiencing a heart attack) reduced all-cause mortality by 31 percent. Current medical guidelines recommend ICD therapy for post-MI patients with an ejection fraction – a common measure of the heart’s pumping function – of 35 percent and below, and after at least 40 days have passed since their heart attack.
For more information:

Related Content

Trial Data Shows Positive Predictive Results for Boston Scientific HeartLogic Heart Failure Diagnostic
News | Heart Failure| October 20, 2017
October 20, 2017 — Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart F
Cardiovascular Risk Significantly Higher in Women With Fatty Liver Disease
News | Womens Healthcare| October 20, 2017
Nonalcoholic fatty liver disease (NAFLD) is associated with significantly higher risk of subsequent cardiovascular...
Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
News | Patient Engagement| October 19, 2017
October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professio
Pregnancy-Related Heart Failure Strikes Black Women Twice as Often as Other Races
News | Womens Healthcare| October 19, 2017
African American women were found to be twice as likely to be diagnosed with peripartum cardiomyopathy as compared to...
The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure| October 18, 2017
October 18, 2017 — The U.S.
MRI May Predict Neurological Outcomes for Cardiac Arrest Survivors
News | Sudden Cardiac Arrest| October 18, 2017
Magnetic resonance imaging (MRI)-based measurements of the functional connections in the brain can help predict long-...
Xarelto Significantly Reduces Major Cardioavascular Events in Stable CAD and PAD Patients
News | Pharmaceuticals| October 18, 2017
October 18, 2017 — Results from the pivotal Phase 3 COMPASS study found that the...
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
Low Mortality and Stroke Risks Displayed for Minimally Invasive Aortic Valve Replacements
News | Heart Valve Technology| October 11, 2017
An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 additional associated...
Overlay Init